HUT47920A - Process for production of triasoles and dopamin-bethahydroxilase hindering compositions containing this substance - Google Patents

Process for production of triasoles and dopamin-bethahydroxilase hindering compositions containing this substance

Info

Publication number
HUT47920A
HUT47920A HU872280A HU228087A HUT47920A HU T47920 A HUT47920 A HU T47920A HU 872280 A HU872280 A HU 872280A HU 228087 A HU228087 A HU 228087A HU T47920 A HUT47920 A HU T47920A
Authority
HU
Hungary
Prior art keywords
triasoles
bethahydroxilase
dopamin
hindering
substance
Prior art date
Application number
HU872280A
Other languages
English (en)
Other versions
HU201530B (en
Inventor
Joseph A Finkelstein
Lawrence I Kruse
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of HUT47920A publication Critical patent/HUT47920A/hu
Publication of HU201530B publication Critical patent/HU201530B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU872280A 1986-05-23 1987-05-21 Process for producing triazoles and dopamin-beta-hydroxylase inhibiting compositions comprising same HU201530B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86643786A 1986-05-23 1986-05-23

Publications (2)

Publication Number Publication Date
HUT47920A true HUT47920A (en) 1989-04-28
HU201530B HU201530B (en) 1990-11-28

Family

ID=25347617

Family Applications (1)

Application Number Title Priority Date Filing Date
HU872280A HU201530B (en) 1986-05-23 1987-05-21 Process for producing triazoles and dopamin-beta-hydroxylase inhibiting compositions comprising same

Country Status (15)

Country Link
EP (1) EP0246888A3 (hu)
JP (1) JPS62283967A (hu)
KR (1) KR870011109A (hu)
CN (1) CN87103808A (hu)
AU (1) AU7334487A (hu)
DK (1) DK251087A (hu)
FI (1) FI872249A7 (hu)
HU (1) HU201530B (hu)
IL (1) IL82542A0 (hu)
NO (1) NO872094L (hu)
NZ (1) NZ220347A (hu)
PH (1) PH23506A (hu)
PT (1) PT84904B (hu)
ZA (1) ZA873653B (hu)
ZW (1) ZW9087A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628059A (en) * 1985-10-31 1986-12-09 Smithklein Beckman Corporation Dopamine-β-hydroxylase inhibitors
DE4230466A1 (de) * 1992-09-11 1994-03-17 Basf Ag Verfahren zur katalytischen Herstellung von Kondensationsprodukten des Formaldehyds
KR101955691B1 (ko) 2010-03-30 2019-03-07 베르선 코포레이션 트롬빈 억제제로서의 다중치환된 방향족 화합물
SG10201707486XA (en) 2013-03-15 2017-10-30 Verseon Corp Halogenopyrazoles as inhibitors of thrombin
CA2901637C (en) 2013-03-15 2019-09-24 Kevin Michael Short Multisubstituted aromatic compounds as serine protease inhibitors
MX2017003624A (es) 2014-09-17 2017-07-13 Verseon Corp Compuestos de piridona sustituida con pirazolilo como inhibidores de serina proteasas.
LT3261639T (lt) 2015-02-27 2022-11-25 Verseon International Corporation Pakaitiniai pirazolo junginiai kaip serino proteazės inhibitoriai

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
US4628059A (en) * 1985-10-31 1986-12-09 Smithklein Beckman Corporation Dopamine-β-hydroxylase inhibitors

Also Published As

Publication number Publication date
PT84904B (en) 1989-07-17
AU7334487A (en) 1987-11-26
FI872249L (fi) 1987-11-24
PH23506A (en) 1989-08-16
NO872094L (no) 1987-11-24
DK251087D0 (da) 1987-05-18
FI872249A0 (fi) 1987-05-21
ZA873653B (en) 1988-08-31
EP0246888A3 (en) 1988-09-28
PT84904A (en) 1987-06-01
CN87103808A (zh) 1987-12-09
NZ220347A (en) 1990-05-28
JPS62283967A (ja) 1987-12-09
FI872249A7 (fi) 1987-11-24
ZW9087A1 (en) 1987-09-02
EP0246888A2 (en) 1987-11-25
HU201530B (en) 1990-11-28
DK251087A (da) 1987-11-24
IL82542A0 (en) 1987-11-30
NO872094D0 (no) 1987-05-19
KR870011109A (ko) 1987-12-21

Similar Documents

Publication Publication Date Title
HUT45895A (en) Process for production of serotomin antagonic compounds and medical preparatives containing such compositions
HUT47561A (en) Process for production of 3-aryloxi-3-substituated propanamids and medical compositions containing them
HUT47568A (en) Process for production of derivatives of tiazepine and medical compositions containing them
HUT45270A (en) Process for production of polipeptides containing nor-statine and nor-cyclostatin
HUT46221A (en) Process for production of medical compositions containing alphusosine
HUT50190A (en) Process for production of n-substituated 1-dezoxinogimiricin and 1-dezoxi-manno-nogimiricin and medical compositions containing them
HUT46912A (en) Process for production of 1,4-dihydro-piridines and medical preparatives containing such compositions
HUT68247A (en) Process for production of 1,5-diaryl-3-substituted-pyrazoles and preparations containing theese compounds
HUT47576A (en) Process for production of 2-amin-purin-derivatives and medical compositions containing them as active substance
PT84936A (en) Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same
PT81746A (en) Process for the preparation of peptide-aldehydes and of pharmaceutical compositions containing them
HUT42953A (en) Process for production of medical compositions
HUT45982A (en) Process for production of microlide compositions and medical preparatives containing such compositions
HUT45986A (en) Process for production of derivatives os tetroquinoline and medical preparatives containing such compositions
HUT45979A (en) Process for production of 5-phenil-2-oxasole-derivatives and medical compositions containing such compounds
PT84358A (en) Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same
HUT50166A (en) Process for production of substituated 3,4-dihydro-rh-benzopiranes and medical compositions containing them
HUT45971A (en) Process for production of new alkon-sulphon-anilid and medical preparatives containing such substances
HU896624D0 (en) Process for preparation of (3-aryl-propyl)-phosphonium-halogenides
PT80794A (en) Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same
HUT47267A (en) Process for production of new pirasoline-derivatives and medical compositions containing them
HUT47572A (en) Process for production of castanospermin esthers and glykozids and mecidal compositions containing them
HUT47594A (en) Process for production of new derivatives of furanuronic acid and medical compositions containing them
HUT42455A (en) Process for production of derivatives of 5-substituated amino-piramidin and medical compositions containing thereof
HUT47920A (en) Process for production of triasoles and dopamin-bethahydroxilase hindering compositions containing this substance

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee